Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F57UW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,587
Award facts
- Contract value 100% obligated
- $30,586.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,586.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg auto-injector pens on January 30, 2026, with completion scheduled for February 2, 2026. This non-set-aside award is performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 single-award vehicle valued through December 2031 that enables comprehensive pharmaceutical and medical supply distribution to support military healthcare programs globally.
This contract represents a routine pharmaceutical procurement within DLA's medical supply chain operations, which provide essential medications and medical commodities to military treatment facilities, the Defense Health Agency, and other federal healthcare systems. Cosentyx is a specialty immunosuppressant medication used to treat autoimmune conditions, and this order fulfills specific demand within the broader pharmaceutical support mission. As a major pharmaceutical distributor serving federal medical procurement needs, Cencora/AmerisourceBergen competes on a full and open basis for such orders and demonstrates established capability in delivering specialty medications and brand-name drugs across multiple therapeutic domains to support military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F57UW?
SPE2DR26F57UW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F57UW worth?
The government has obligated $30,587 on SPE2DR26F57UW.
Is contract SPE2DR26F57UW an order under another contract?
Yes. SPE2DR26F57UW is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57UW competed?
The extent of competition for SPE2DR26F57UW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award